PAPER
Effective Synthesis of 4-Aryl-2-diethoxyphosphoryl-4-oxobutanoates
1675
C), 134.4 (s, Ar-C), 168.3 (d, J = 5.6 Hz, C-1), 200.1 (d, J = 15.7
Hz, C-4).
31P NMR (CDCl3): d = 23.02.
13C NMR (CDCl3): d = 13.4 [s, C(O)OCH2CH3], 15.8 [d, J = 5.8
Hz, P(O)(OCH2CH3)2], 16.3 (s, CH3C-3), 39.9 (s, C-3), 47.8 (d,
J = 130.7 Hz, C-2), 60.9 [s, C(O)OCH2CH3], 62.3 [d, J = 7.1 Hz,
P(O)(OCH2CH3)2], 62.4 [d, J = 8.1 Hz, P(O)(OCH2CH3)2], 127.8
(s, Ar-C), 129.5 (s, 2 × Ar-C), 131.5 (s, 2 × Ar-C), 133.6 (s, Ar-C),
168.1 (d, J = 5.2 Hz,C-1), 200.5 (d, J = 16.9 Hz, C-4).
Anal. Calcd for C20H25O6P: C, 61.22; H, 6.42. Found: C, 61.39; H,
6.28.
31P NMR (CDCl3): d = 22.27.
Ethyl 4-Aryl-2-diethoxyphosphoryl-3-methyl-4-oxobutanoates
13a–c; General Procedure
Ethyl anti-4-(4-Bromophenyl)-2-(diethoxyphosphoryl)-3-meth-
yl-4-oxobutanoate (anti-13b)
To a suspension of NaH (0.45 g, 18.7 mmol) in DMSO (30 mL) and
THF (5 mL), a solution of ethyl 2-diethoxyphosphorylacetate (5;
4.0 g, 17.8 mmol) in THF (5 mL) was added. The mixture was
stirred r.t. for 0.5 h, cooled to 0 °C and a solution of the appropriate
1-aryl-2-bromopropan-1-one 12a–c (17.8 mmol) and TBAI (0.69 g,
10 mol%) in THF (20 mL) was added dropwise. After stirring for
20 h at this temperature, the reaction mixture was diluted with H2O
(50 mL) and extracted with CH2Cl2 (3 × 25 mL). The combined or-
ganic layers were washed with H2O (20 mL) and dried (MgSO4).
The solvent was evaporated and the crude product was purified by
column chromatography (silica gel, EtOAc–hexane, 4:1).
1H NMR (CDCl3): d = 1.18–1.28 [m, 9 H, P(O)(OCH2CH3)2, CH3],
1.33 [t, J = 7.1 Hz, 3 H, C(O)OCH2CH3], 3.66 (dd, J = 21.2, 10.2
Hz, 1 H, H-2), 3.96–4.21 [m, 5 H, P(O)(OCH2CH3)2, H-3], 4.27 [q,
J = 7.1 Hz, 2 H, C(O)OCH2CH3], 7.59–7.89 (m, 4 H, Ar-H).
13C NMR (CDCl3): d = 13.7 [s, C(O)OCH2CH3], 15.7 [d, J = 5.9
Hz, P(O)(OCH2CH3)2], 15.8 [d, J = 5.7 Hz, P(O)(OCH2CH3)2],
16.5 (d, J = 14.1 Hz, CH3C-3), 38.9 (d, J = 3.6 Hz, C-3), 47.6 (d,
J = 129.5 Hz, C-2), 61.1 [s, C(O)OCH2CH3], 62.3 [d, J = 7.2 Hz,
P(O)(OCH2CH3)2], 62.5 [d, J = 7.4 Hz, P(O)(OCH2CH3)2], 127.9
(s, Ar-C), 129.7 (s, 2 × Ar-C), 131.6 (s, 2 × Ar-C), 134.2 (s, Ar-C),
167.5 (d, J = 4.8 Hz, C-1), 199.5 (d, J = 3.2 Hz, C-4).
Ethyl 2-(Diethoxyphosphoryl)-3-methyl-4-oxo-4-phenyl-
butanoate (13a)
Yield: 5.0 g (79%); yellow oil; mixture of diastereoisomers in a
65:35 ratio; Rf = 0.36, 0.38 (EtOAc–hexane, 4:1).
31P NMR (CDCl3): d = 21.55.
Ethyl 2-(Diethoxyphosphoryl)-4-(4-methoxyphenyl)-4-methyl-
4-oxobutanoate (13c)
IR (film): 1732, 1684, 1252 cm–1.
Yield: 5.8 g (84%); yellow oil; mixture of diastereoisomers in a
65:35 ratio; Rf = 0.38, 0.42 (EtOAc–hexane, 4:1).
IR (film): 1732, 1676, 1256 cm–1.
1H NMR (CDCl3): d [major diastereomer (syn)]11 = 1.15–1.42 [m,
12 H, P(O)(OCH2CH3)2, C(O)OCH2CH3, CH3], 3.51 (dd, J = 21.4,
11.0 Hz, 1 H, H-2), 3.80 (s, 3 H, OCH3), 3.96–4.33 [m, 7 H,
P(O)(OCH2CH3)2, C(O)OCH2CH3, H-3], 6.94–8.04 (m, 4 H, Ar-
H).
1H NMR (CDCl3): d [major diastereomer (syn)]11 = 1.15–1.41 [m,
12 H, P(O)(OCH2CH3)2, C(O)OCH2CH3, CH3], 3.50 (dd, J = 21.6,
11.0 Hz, 1 H, H-2), 4.00–4.30 [m, 7 H, P(O)(OCH2CH3)2,
C(O)OCH2CH3, H-3], 7.40–7.60 (m, 5 H, Ar-H).
1H NMR (CDCl3): d [minor diastereomer (anti)]11 = 1.15–1.41 [m,
12 H, P(O)(OCH2CH3)2, C(O)OCH2CH3, CH3], 3.69 (dd, J = 21.2,
10.0 Hz, 1 H, H-2), 4.00–4.30 [m, 7 H, P(O)(OCH2CH3)2,
C(O)OCH2CH3, H-3], 7.40–7.60 (m, 5 H, Ar-H).
13C NMR (CDCl3): d [major diastereomer (syn)]11 = 13.3 [s,
C(O)OCH2CH3)], 15.5 (d, J = 5.2 Hz, P(O)(OCH2CH3)2], 16.2 (d,
J = 6.5 Hz, CH3C-3), 39.7 (s, C-3), 47.2 (d, J = 129.4 Hz, C-2), 60.6
[s, C(O)OCH2CH3], 61.9 [d, J = 15.5 Hz, P(O)(OCH2CH3)2], 127.5
(s, 2 × Ar-C), 127.8 (s, 2 × Ar-C), 132.4 (s, Ar-C), 134.4 (s, Ar-C),
167.3 (s, C-1), 199.9 (s, C-4).
13C NMR (CDCl3): d [minor diastereomer (anti)]11 = 13.1 [s,
C(O)OCH2CH3], 15.3 (d, J = 3.4 Hz, P(O)(OCH2CH3)2], 16.1 (d,
J = 5.3 Hz, CH3C-3), 38.5 (s, C-3), 47.7 (d, J = 130.6 Hz, C-2), 60.5
[s, C(O)OCH2CH3], 61.8 [d, J = 9.3 Hz, P(O)(OCH2CH3)2], 127.5
(s, 2 × Ar-C), 127.8 (s, 2 × Ar-C), 132.4 (s, Ar-C), 134.8 (s, Ar-C),
168.0 (s, C-1), 201.5 (d, J = 16.5 Hz, C-4).
1H NMR (CDCl3): d [minor diastereomer (anti)]11 = 1.15–1.42 [m,
12 H, P(O)(OCH2CH3)2, C(O)OCH2CH3, CH3], 3.69 (dd, J = 21.0,
10.1 Hz, 1 H, H-2), 3.91 (s, 3 H, OCH3), 3.96–4.33 [m, 7 H,
P(O)(OCH2CH3)2, C(O)OCH2CH3, H-3], 6.94–8.04 (m, 4 H, Ar-
H).
13C NMR (CDCl3): d [major diastereomer (syn)]11 = 13.2 [s,
C(O)OCH2CH3], 15.6 [d, J = 5.9 Hz, P(O)(OCH2CH3)2], 16.5 (s,
CH3C-3), 39.4 (s, C-3), 47.8 (d, J = 130.3 Hz, C-2), 54.8 (s, CH3O),
60.6 [s, C(O)OCH2CH3], 62.1 [d, J = 7.8 Hz, P(O)(OCH2CH3)2],
62.2 [d, J = 7.7 Hz, P(O)(OCH2CH3)2], 113.2 (s, 2 × Ar-C), 127.4
(s, Ar-C), 130.1 (s, 2 × Ar-C), 163.1 (s, Ar-C), 168.1 (d, J = 5.3 Hz,
C-1), 199.7 (d, J = 16.9 Hz, C-4).
31P NMR (CDCl3): d = 22.58 (major); 21.71 (minor).11
13C NMR (CDCl3): d [minor diastereomer (anti)]11 = 13.4 [s,
C(O)OCH2CH3], 15.5 [d, J = 5.6 Hz, P(O)(OCH2CH3)2], 15.4 [d,
J = 5.6 Hz, P(O)(OCH2CH3)2], 16.4 (s, CH3C-3), 38.1 (d, J = 3.5
Hz, C-3), 47.3 (d, J = 129.7 Hz, C-2), 54.8 (s, CH3O), 60.7 [s,
C(O)OCH2CH3], 61.9 [d, J = 8.8 Hz, P(O)(OCH2CH3)2], 62.1 [d,
J = 7.9 Hz, P(O)(OCH2CH3)2], 113.2 (s, 2 × Ar-C), 127.9 (s, Ar-C),
130.1 (s, 2 × Ar-C), 163.1 (s, Ar-C), 167.5 (d, J = 4.6 Hz, C-1),
198.4 (d, J = 3.2 Hz, C-4).
Anal. Calcd for C17H25O6P: C, 57.30; H, 7.07. Found: C, 57.41; H,
7.21.
Ethyl 4-(4-Bromophenyl)-2-(diethoxyphosphoryl)-3-methyl-4-
oxobutanoate (13b)
Yield: 5.5 g (71%); yellow oil; mixture of diastereoisomers in a
60:40 ratio; Rf = 0.42, 0.53 (EtOAc–hexane, 4:1).
31P NMR (CDCl3): d = 22.81 (major), 21.78 (minor).11
IR (film): 1732, 1688, 1256 cm–1.
Anal. Calcd for C18H27O7P: C, 55.95; H, 7.04. Found: C, 56.15; H,
7.21.
Anal. Calcd for C17H24BrO6P: C, 46.91; H, 5.56. Found: C, 46.85;
H, 5.69.
Ethyl 2-(Diethoxyphosphoryl)-3-methyl-4-(naphthalen-1-yl)-4-
oxobutanoate (13d)
To a suspension of NaH (0.45 g, 18.7 mmol) in THF (30 mL), a so-
lution of ethyl 2-diethoxyphosphorylacetate (5; 4.0 g, 17.8 mmol) in
THF (5 mL) was added. The mixture was stirred at r.t. for 30 min,
cooled to 0 °C and a solution of 2-bromo-1-(naphthalen-1-yl)pro-
Ethyl syn-4-(4-Bromophenyl)-2-(diethoxyphosphoryl)-3-meth-
yl-4-oxobutanoate (syn-13b)
1H NMR (CDCl3): d = 1.18 [t, J = 7.1 Hz, 3 H, C(O)OCH2CH3],
1.33–1.41 [m, 9 H, P(O)(OCH2CH3)2, CH3], 3.49 (dd, J = 21.7, 10.9
Hz, 1 H, H-2), 4.10 [q, J = 7.1 Hz, 2 H, C(O)OCH2CH3], 4.13–4.29
[m, 5 H, P(O)(OCH2CH3)2, H-3], 7.60–7.90 (m, 4 H, Ar-H).
Synthesis 2007, No. 11, 1671–1676 © Thieme Stuttgart · New York